doi: 10.3389/fncel.2010.00005.
eCollection 2010.
How do Soluble Oligomers of Amyloid beta-protein Impair Hippocampal Synaptic Plasticity?
Affiliations
- PMID: 20428510
- PMCID: PMC2859875
- DOI: 10.3389/fncel.2010.00005
Item in Clipboard
How do Soluble Oligomers of Amyloid beta-protein Impair Hippocampal Synaptic Plasticity?
Front Cell Neurosci.
.
No abstract available
Comment on
-
Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake.Neuron. 2009 Jun 25;62(6):788-801. doi: 10.1016/j.neuron.2009.05.012. Neuron. 2009. PMID: 19555648 Free PMC article.
Similar articles
-
Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate.J Neurosci. 2017 Jan 4;37(1):152-163. doi: 10.1523/JNEUROSCI.1698-16.2016. J Neurosci. 2017. PMID: 28053038 Free PMC article.
-
Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.Neurobiol Dis. 2016 Jul;91:124-131. doi: 10.1016/j.nbd.2016.03.001. Epub 2016 Mar 3. Neurobiol Dis. 2016. PMID: 26949218 Free PMC article.
-
Soluble amyloid-beta peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo.Brain. 2008 Sep;131(Pt 9):2414-24. doi: 10.1093/brain/awn174. Epub 2008 Aug 4. Brain. 2008. PMID: 18678563
-
Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.Biochem Soc Trans. 2005 Aug;33(Pt 4):563-7. doi: 10.1042/BST0330563. Biochem Soc Trans. 2005. PMID: 16042545 Review.
-
The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention.Biochem Soc Trans. 2005 Nov;33(Pt 5):1087-90. doi: 10.1042/BST20051087. Biochem Soc Trans. 2005. PMID: 16246051 Review.
Cited by
-
Molecular mechanism of misfolding and aggregation of Aβ(13-23).J Phys Chem B. 2013 May 23;117(20):6175-86. doi: 10.1021/jp402938p. Epub 2013 May 15. J Phys Chem B. 2013. PMID: 23642026 Free PMC article.
-
Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4.Alzheimers Res Ther. 2010 Oct 29;2(5):31. doi: 10.1186/alzrt55. Alzheimers Res Ther. 2010. PMID: 21062519 Free PMC article. No abstract available.
-
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study.Sci Rep. 2017 Jan 3;7:39471. doi: 10.1038/srep39471. Sci Rep. 2017. PMID: 28045051 Free PMC article. Clinical Trial.
-
Neuroinflammatory challenges compromise neuronal function in the aging brain: Postoperative cognitive delirium and Alzheimer's disease.Behav Brain Res. 2017 Mar 30;322(Pt B):269-279. doi: 10.1016/j.bbr.2016.08.027. Epub 2016 Aug 17. Behav Brain Res. 2017. PMID: 27544872 Free PMC article. Review.
-
Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of AβPP transgenic mice.J Alzheimers Dis. 2011;25(2):295-307. doi: 10.3233/JAD-2011-101986. J Alzheimers Dis. 2011. PMID: 21422528 Free PMC article.
References
-
- Duerson K., Woltjer R. L., Mookherjee P., Leverenz J. B., Montine T. J., Bird T. D., Pow D. V., Rauen T., Cook D. G. (2009). Detergent-insoluble EAAC1/EAAT3 aberrantly accumulates in hippocampal neurons of Alzheimer's disease patients. Brain Pathol. 19, 267–27810.1111/j.1750-3639.2008.00186.x - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
